Mkts

LifeMD, Inc.

NASDAQ: LFMD
$1.70-0.10 (-5.83%)
As of Nov 18, 9:30 AM ET

Key statistics

Day range
1.671.81
52-week range
1.605.38
Today
Open1.75
Previous close1.70
Volume736.5K
Valuation
Market cap86.76M
P/E ratio431.62×
EPS (TTM)0.01
Income & risk
Dividend / yield—
Beta2.17
Avg volume1.87M
Discussion

LFMD News

Stories mentioning LFMD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue50,16320,32260,17262,67350,8886,74653,27250,662
Cost of Goods Sold5,9254,7407,4087,4318,1366,8025,0145,025
Gross Profit44,23715,58252,76555,24242,751(57.00)48,25945,637
Operating Expenses
Research & Development
Sales General & Admin
Total Operating Expenses53,16719,64954,73455,69443,9333,87352,25551,942
Operating Income (Loss)(8,929)(4,067)(1,969)(452.00)(1,182)(3,929)(3,996)(6,306)
Interest Income
Interest Expense(56.00)(28.00)262.00663.00464.00607.00559.00531.00
Other Expense
Pretax Income(8,873)(3,388)(1,645)(4,555)
Tax Provision169.00233.00
Net Income (Loss)(8,873)19,964(3,806)(1,620)(184.00)(3,107)(4,658)(6,876)
Earnings Per Share (Basic)(0.20)0.44(0.05)(0.02)(0.08)(0.13)
Earnings Per Share (Diluted)(0.20)0.44(0.05)(0.02)(0.08)(0.13)
Weighted Average Shares Outstanding (Basic)47,33645,13046,16344,40243,13641,19642,02141,296
Weighted Average Shares Outstanding (Diluted)47,33645,13046,16344,40243,13641,19642,02141,296

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About LFMD

LifeMD, Inc. (NASDAQ: LFMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol LFMD. It last traded at $1.70 (Nov 18, 2026, 9:30 AM ET), down 5.8% on the day. That gives LifeMD a market capitalisation of $86.8M and a price-to-earnings ratio of 431.6.

Over the past 52 weeks LFMD has traded between $1.60 and $5.38.

Revenue for the quarter ended Mar 31, 2026 was $50.2M; a net loss of $8.9M. Revenue was down 1.4% from $50.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$50.2M-$8.9M-17.7%
Dec 31, 2025$20.3M$20.0M98.2%
Sep 30, 2025$60.2M-$3.8M-6.3%
Jun 30, 2025$62.7M-$1.6M-2.6%

From LifeMD’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…